MD FACC - Avinger Chief Officer
| AVGR Stock | USD 0.84 0.01 1.20% |
Executive
MD FACC is Chief Officer of Avinger
| Address | 400 Chesapeake Drive, Redwood City, CA, United States, 94063 |
| Phone | (650) 241-7900 |
| Web | https://avinger.com |
Avinger Management Efficiency
The company has return on total asset (ROA) of (0.6522) % which means that it has lost $0.6522 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (33.3259) %, meaning that it created substantial loss on money invested by shareholders. Avinger's management efficiency ratios could be used to measure how well Avinger manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Avinger's Return On Capital Employed is relatively stable compared to the past year. As of 11/29/2024, Return On Equity is likely to grow to 3.10, while Return On Tangible Assets are likely to drop (1.40). At this time, Avinger's Total Assets are relatively stable compared to the past year. As of 11/29/2024, Total Current Assets is likely to grow to about 20.1 M, while Non Currrent Assets Other are likely to drop slightly above 18.1 K.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Thomas Adams | Repro Med Systems | 51 | |
| James Cardwell | GlucoTrack | 63 | |
| Niro Ramachandran | Akoya Biosciences | 49 | |
| Christian Voigtlander | ICU Medical | 56 | |
| Brianne McGuire | Nephros | N/A | |
| Juan Serna | AngioDynamics | N/A | |
| Marna BronfenMoore | AngioDynamics | 57 | |
| Mary Skafidas | AptarGroup | N/A | |
| Andy Molnar | Milestone Scientific | 62 | |
| JD CFA | Akoya Biosciences | N/A | |
| Scott Centea | AngioDynamics | 45 | |
| Clay Schwabe | Precision Optics, | N/A | |
| Priyam Shah | Akoya Biosciences | N/A | |
| Jaoquin Abondano | Innovative Eyewear | 40 | |
| Daniel Ackerman | AptarGroup | 51 | |
| Judy CFA | Nephros | 59 | |
| Rob Cannon | Repro Med Systems | N/A | |
| Shiela Vinczeller | AptarGroup | 60 | |
| Christopher Pazdan | Repro Med Systems | N/A | |
| Kenneth Miller | Repro Med Systems | 55 | |
| Drinda Benjamin | GlucoTrack | 48 | |
Management Performance
| Return On Equity | -33.33 | ||||
| Return On Asset | -0.65 |
Avinger Leadership Team
Elected by the shareholders, the Avinger's board of directors comprises two types of representatives: Avinger inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avinger. The board's role is to monitor Avinger's management team and ensure that shareholders' interests are well served. Avinger's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avinger's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Keith Schaefer, Chief Officer | ||
| Corey Gibbs, Vice Sales | ||
| Nabeel Subainati, Principal Finance | ||
| Himanshu Patel, Chief Officer | ||
| Jeffrey Soinski, CEO and President and Director | ||
| MD FACC, Chief Officer | ||
| Philip Preuss, Vice President - Corporate Development |
Avinger Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avinger a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -33.33 | ||||
| Return On Asset | -0.65 | ||||
| Profit Margin | (2.61) % | ||||
| Operating Margin | (2.23) % | ||||
| Current Valuation | 2.35 M | ||||
| Shares Outstanding | 3.2 M | ||||
| Shares Owned By Insiders | 13.60 % | ||||
| Shares Owned By Institutions | 2.83 % | ||||
| Number Of Shares Shorted | 65.04 K | ||||
| Price To Earning | (0.13) X |
Pair Trading with Avinger
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avinger position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avinger will appreciate offsetting losses from the drop in the long position's value.Moving together with Avinger Stock
Moving against Avinger Stock
| 0.75 | ELMD | Electromed | PairCorr |
| 0.72 | MD | Mednax Inc | PairCorr |
| 0.62 | VREX | Varex Imaging Corp | PairCorr |
| 0.59 | DOCS | Doximity Sell-off Trend | PairCorr |
| 0.55 | OM | Outset Medical | PairCorr |
The ability to find closely correlated positions to Avinger could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avinger when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avinger - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avinger to buy it.
The correlation of Avinger is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avinger moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avinger moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avinger can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Avinger Stock Analysis
When running Avinger's price analysis, check to measure Avinger's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avinger is operating at the current time. Most of Avinger's value examination focuses on studying past and present price action to predict the probability of Avinger's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avinger's price. Additionally, you may evaluate how the addition of Avinger to your portfolios can decrease your overall portfolio volatility.